S&P Futures
4,293.00 -5.25 (-0.12%) Dow Futures
33,844.00 -29.00 (-0.09%) Nasdaq Futures
13,665.75 -15.50 (-0.11%) Russell 2000 Futures
2,021.80 -2.00 (-0.10%) Crude Oil
88.28 -1.13 (-1.26%) Gold
1,792.40 -5.70 (-0.32%)
TXMD Jan 2023 3.000 put
| Previous Close | 0.8500 |
| Open | 0.8500 |
| Bid | 0.1500 |
| Ask | 2.5500 |
| Strike | 3.00 |
| Expire Date | 2023-01-20 |
| Day's Range | 0.8500 - 0.8500 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 153 |
- Motley Fool
TherapeuticsMD, Inc. (TXMD) Q2 2022 Earnings Call Transcript
Good morning, everyone, and thank you for joining today to discuss our second quarter financial results and business update. This morning, TherapeuticsMD issued a press release announcing its second quarter 2022 financial results. The press release and accompanying presentation are available on the company's website TherapeuticsMD in the investors and media section.
- Zacks
TherapeuticsMD (TXMD) Reports Q2 Loss, Tops Revenue Estimates
TherapeuticsMD (TXMD) delivered earnings and revenue surprises of 29.28% and 23.11%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
- Business Wire
TherapeuticsMD Announces Second Quarter 2022 Financial Results
BOCA RATON, Fla., August 15, 2022--TherapeuticsMD, Inc. ("TXMD" or the "Company") (NASDAQ: TXMD), an innovative, leading women’s healthcare company, today reported financial results for the Second Quarter ended June 30, 2022.
